|1.||Sugaya, Kimio: 1 article (05/2012)|
|2.||Ashitomi, Katsuhiro: 1 article (05/2012)|
|3.||Nishijima, Saori: 1 article (05/2012)|
|4.||Yamamoto, Hideyuki: 1 article (05/2012)|
|5.||Kadekawa, Katsumi: 1 article (05/2012)|
|6.||Tateishi, Yoshihisa: 1 article (02/2012)|
|7.||Yatsuki, Henry: 1 article (02/2012)|
|8.||Sadahiro, Tomohito: 1 article (02/2012)|
|9.||Oda, Shigeto: 1 article (02/2012)|
|10.||Setoguchi, Daisuke: 1 article (02/2012)|
|1.||Neurogenic Urinary Bladder (Bladder, Neurogenic)
05/01/2004 - "He had been administered distigmine bromide orally for over two years at a daily dosage of 10 mg as a treatment for underactive neurogenic bladder. "
05/01/2004 - "[A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder]."
01/20/1973 - "Preliminary report on the effect of distigmine bromide on the neurogenic bladder."
12/01/2011 - "Distigmine bromide is a cholinesterase inhibitor widely used for the treatment of hypotonic neurogenic bladder. "
02/01/1968 - "[Clinical evaluation of Ubretid on neurogenic bladder dysfunction and on high serum beta-glucuronidase]."
06/01/1997 - "Distigmine is widely used for the treatment of dysuria, which is caused by various types of psychotropic medications. "
06/01/1997 - "Of the twelve patients treated with distigmine for dysuria caused by psychotropic drugs six patients presented both adverse cholinergic effects and decreased levels of serum AChE and BChE. "
01/01/1967 - "[Treatment of dysuria with anticholinesterases: Ubretid]."
|3.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/01/1992 - "We report the results of a comparative study on the clinical efficacy of the single use of distigmine bromide and its combined use with prazosin hydrochloride in the treatment of benign prostatic hypertrophy. "
01/01/2002 - "A 78-year-old man with duodenal ulcer complained of nocturia, and was administered distigmine bromide 10 mg daily under the diagnosis of mild benign prostatic hypertrophy with underactive neurogenic bladder. "
09/01/1992 - "In conclusion, distigmine bromide and distigmine bromide+prazosin hydrochloride are considered very useful for the treatment of miturition disturbance due to benign prostatic hypertrophy."
09/01/1992 - "[Clinical effects of distigmine bromide (Ubretid), a cholinesterase inhibitor, on micturition disturbance by benign prostatic hypertrophy--comparative study of distigmine bromide and the combination of distigmine bromide and adrenergic blocker]."
12/01/1989 - "Severe neurogenic pain has been successfully treated with physostigmine or distigmine."
03/01/1989 - "We therefore conclude that a combination of amitriptyline and distigmine (both given ab initio) may be a useful therapy for chronic pain."
03/01/1989 - "The addition of distigmine to preexisting (and ineffective) amitriptyline treatment failed to relieve pain. "
03/01/1989 - "Sixty-five patients attending a pain relief clinic were randomly allocated to treatment for 5 weeks with amitriptyline alone, distigmine alone, amitriptyline and distigmine started together, or addition of distigmine to preexisting treatment with amitriptyline. "
03/01/1989 - "Distigmine and amitriptyline in the treatment of chronic pain."
|1.||distigmine (distigmine bromide)